A Bioethics Conversation: What's Next for Psychedelics?

Psychedelic medicine is at a pivotal moment. With increased interest from the public, practitioners, and policymakers—including a recent executive order to speed up review of certain psychedelic drugs—ethics questions about how these therapies are regulated, studied, and administered have taken on new urgency. The Greenwall Foundation held a webinar featuring panelists I. Glenn Cohen, JD; Amy McGuire, JD, PhD; and David B. Yaden, PhD to explore these questions and more.